Targeted proteomic search reveals new actors in the synaptic and lysosomal dysfunction in genetic FTD, a GENFI study.
Sophia Weiner(Institute of Neurobiology), Aitana Sogorb‐Esteve(UK Dementia Research Institute), Sandro Sorbi(University of Florence), Caroline Graff(Karolinska Institutet), Joel Simrén(University of Gothenburg), Maria Carmela Tartaglia, James B. Rowe(MRC Cognition and Brain Sciences Unit), Kaj Blennow(Sahlgrenska University Hospital), Alexander Gerhard(University of Manchester), Christopher Butler(Pontificia Universidad Católica de Chile), Matthis Synofzik(German Center for Neurodegenerative Diseases), Imogen J. Swift(UK Dementia Research Institute), Johannes Levin(The University of Melbourne), Alexandre de Mendonça(University of Lisbon), Isabelle Le Ber(Inserm), Raquel Sánchez‐Valle(Biomedical Research Networking Center on Neurodegenerative Diseases), Mathias Sauer(Sahlgrenska University Hospital), Harro Seelaar(Erasmus MC), Pietro Tiraboschi(Mayo Clinic in Florida), Florence Pasquier(Centre Hospitalier Universitaire de Lille), Isabel Santana(Hospitais da Universidade de Coimbra), Lize C. Jiskoot(Erasmus MC), Jonathan D. Rohrer(University Memory and Aging Center), Markus Otto(University Hospital in Halle), Rik Vandenberghe(Allen Institute for Brain Science), Elizabeth Finger(Western University), Carolin Heller(UK Dementia Research Institute), Daniela Galimberti(University of Milan), Mario Masellis(Sunnybrook Health Science Centre), Fermín Moreno(Instituto de Salud Carlos III), Robert Laforce(Université Laval), Barbara Borroni(Centro San Giovanni di Dio Fatebenefratelli), Frederika Malichova(UK Dementia Research Institute), Simon Ducharme(Montreal Neurological Institute and Hospital), John C. van Swieten(Erasmus MC), Kathryn Knowles(UK Dementia Research Institute), Henrik Zetterberg(University of Wisconsin System), Johan Gobom(Sahlgrenska University Hospital)
Cited by 0
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k